Nearly 80% of people taking calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) for the preventive treatment of migraine reported their migraine as “better” overall since…
Investigators from Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center have conducted the largest prospective study using objective measures of sleep to date…
New York’s Montefiore Headache Center helped conduct a large-scale clinical trial testing Allergan’s ubrogepant with migraine headache patients. The new drug shows promise. Migraine: A…
NYU Langone Health led migraine focused digital therapy study and reports that patients who used the app at least two times a week had fewer…
NY School of Medicine, Langone Health researchers teamed up with Irody Inc. to jointly develop an innovative new smartphone relaxation app called RELAXaHEAD for those…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
